MedTrace Logo

Evaluation of Efficacy and Safety of AGP on Immune Enhancement

NCT03330392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-11-08

No results posted yet for this study

Summary

The researchers investigated the immune enhancing effects of AGP for Korean participants.

Conditions

  • Immune Function

Interventions

DIETARY_SUPPLEMENT

AGP

take two tablets per day (500 mg/day) for 8 weeks

DIETARY_SUPPLEMENT

Placebo

take two tablets per day (500 mg/day) for 8 weeks

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2017-09-07
Completion
2017-10-27

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03330392 on ClinicalTrials.gov